COVID-19 Update: AquAffirm launches eChem-Gold™ thin-film planar gold electrodes for COVID-19 biosensor research

London, UK

BNC’s parent company, AquAffirm, is pleased to announce that it has launched a range of thin-film planar gold electrodes which are ideal for electrochemistry research associated with COVID-19 biosensor development.

AquAffirm’s thin-film planar gold electrodes are fabricated using high-resolution laser ablation of sputtered gold on a PET substrate with the cell volume delimited by screen-printed hydrophobic ink. Precision manufacture ensures excellent consistency and sensor-to-sensor reproducibility. With counter electrode, working electrode and screen-printed reference electrode made of Ag/AgCl, these electrodes are designed for robust electrochemistry research, with excellent sensor-to-sensor reproducibility a key requirement.

Together with biomedical/diagnostic applications, these electrodes are ideal for electrochemistry research and analysis in environmental, clinical or agri-food areas and for development of electrochemistry-based biosensors.

Commenting on the project launch, AquAffirm CEO Dr David Sarphie said: “We are delighted to be able to make these precision-manufactured electrodes available for researchers developing new sensors and tests for COVID-19. With the world in desperate need of more rapid, near-patient tests for both the coronavirus antigen and its associated antibodies, we believe these electrodes will prove a useful basis for academic groups and companies developing these tests.”

About AquAffirm

AquAffirm is a London-based product development company commercialising technologies to address global biomedical and environmental issues. Offering both hardware and digital solutions, the company is focused on tackling some of the world’s most intractable problems. With a world class board comprising a PowderJect co-founder (Dr David Sarphie, CEO), a co-inventor of the blood glucose test (Prof Tony Cass of Imperial College), a world-renowned microwave engineer and physicist (Prof Gabriel Aeppli FRS of ETH in Switzerland) and an internationally-recognised former director of large UK laboratories (Prof John Wood FREng), AquAffirm is a leader in developing advanced technology solutions.